Journal of Clinical Microbiology, April 1998, p. 1083-1089, Vol. 36, No. 4
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Biology Unit,
Received 23 December 1996/Returned for modification 21 April
1997/Accepted 17 December 1997
A typing procedure for Staphylococcus aureus was
developed based on improved PCR amplification of the coagulase gene and
restriction fragment length polymorphism (RFLP) analysis of the
product. All coagulase-positive staphylococci produced a single PCR
amplification product of either 875, 660, 603, or 547 bp. Those strains
of epidemic methicillin-resistant S. aureus 16 (EMRSA-16)
studied all gave a product of 547 bp. PCR products were digested with
AluI and CfoI, and the fragments were separated
by gel electrophoresis. Ten distinct RFLP patterns were found among 85 isolates of methicillin-resistant S. aureus (MRSA) and 10 propagating strains (PS) of methicillin-sensitive S. aureus
(MSSA) examined. RFLP patterns 1, 2, and 3 were specific to strains of
EMRSA-3, -15, and -16, respectively. By contrast, RFLP patterns 4 and 5 were seen with a heterogeneous collection of strains, together with
drug-resistant forms of S. aureus isolated in Europe and
four propagating strains used for the international phage set. RFLP
pattern 6 was given by the Airedale isolate and PS 95. RFLP pattern 7 encompassed EMRSA-2 (isolate 331), PS 94, and PS 96. An isolate from
Germany gave RFLP pattern 8. Eight strains of MSSA gave patterns
similar to those of methicillin-resistant strains (RFLP patterns 3, 4, 5, 6, and 7), but two, PS 42E and PS 71, gave unique RFLP patterns 9 and 10, respectively. The coagulase gene PCR products for 24 isolates
of MRSA and two isolates of MSSA were sequenced for both strands. The
sequences were aligned, and evolutionary lineages were inferred based
on pairwise distances between isolates.
Resistance to methicillin was first
described for Staphylococcus aureus in 1960, shortly after
the introduction of the drug into clinical practice (20).
Since then, methicillin-resistant S. aureus (MRSA) has
become a widely recognized cause of morbidity and mortality throughout
the world (16).
Accurate and rapid typing of S. aureus is crucial to the
control of infectious organisms (37), and numerous methods
have been described elsewhere (8, 19, 28). A bacteriophage
typing scheme for S. aureus has been agreed on
internationally since 1951, but although it remains a cost-effective
approach to typing the large number of referred isolates, it has some
limitations. The reagents are not commercially available, and in some
instances and certain parts of the world, MRSA strains are nontypeable
with phages (5). Of the other methods, plasmid analysis has
drawbacks, since the plasmids may be absent from isolates, may vary in
size, or may be readily lost (18), and antibiogram schemes
are often uninformative, as many strains are multiply drug resistant
(6).
Recently, several investigators have described DNA-based techniques for
typing strains (13, 17, 34, 40). Pulsed-field gel
electrophoresis (PFGE) is now recognized as being the most discriminatory method for gene typing strains of S. aureus,
and it has been used to investigate nosocomial outbreaks (4,
39). However, PFGE is costly and technically complex and lacks an
agreed criterion for the interpretation of banding patterns (4,
9). Furthermore, for most national reference centers, it is not
practical to use PFGE to type the large numbers of referred isolates.
In the 1980s, epidemic methicillin-resistant S. aureus 1 (EMRSA-1) was the principal MRSA strain identified by phage typing in
England (27). By 1986, a further 13 EMRSA strains were
recognized (EMRSA-2 to EMRSA-14). Recently, EMRSA-15 and EMRSA-16 were
described (12, 31). Currently, the major United Kingdom
EMRSA strains are 3, 15, and 16. In 1996, these comprised approximately
50% of the isolates referred for phage typing to our staphylococcus reference service (1). However, some strains phage typed
weakly or not at all, even at a 100× routine test dilution (RTD). To confirm phage type and/or to answer particular epidemiological questions, PFGE has been used periodically, and yet an alternative rapid and cost-effective confirmatory test would be of value in clinical and reference centers.
Coagulase is produced by all strains of S. aureus
(24). Its production is the principal criterion used in the
clinical microbiology laboratory for the identification of S. aureus in human infections, and it is thought to be an important
virulence factor. The sizes and DNA restriction endonuclease site
polymorphisms at the 3' coding region of the coagulase gene have been
utilized in PCR-based restriction fragment length polymorphism (RFLP)
analysis of S. aureus (15, 25, 26, 29, 38, 39).
We describe here a coagulase gene-based PCR RFLP technique that
differentiated among the major current United Kingdom EMRSA strains,
i.e., EMRSA-3, EMRSA-15, and EMRSA-16, as well as minor epidemic
strains. The PCR primers were designed to encompass the entire 3'
repeat elements, thereby avoiding the variable regions within the
coagulase gene. Comparisons between DNA sequence data from the 3'
variable region of the coagulase gene then allowed phylogenetic groups
to be identified and permitted inferences to be drawn about some of the
lineages of S. aureus.
Bacterial strains.
Bacterial strains were examined under a
code that was broken upon completion of the analysis of the results.
Eighty-five S. aureus strains representing EMRSA-1 to -16, including the original Jevons strain (NCTC 10442) and two duplicates,
together with 10 methicillin-sensitive S. aureus propagating
strains (PS), were studied (Table 1)
(2, 12, 31, 33, 34, 41). Negative controls comprising three
coagulase-negative staphylococcal species, S. epidermidis
(NCTC 11047), S. haemolyticus (NCTC 11042), and S. saprophyticus (NCTC 7292), were also included. Bacteria were grown
overnight on blood agar plates at 37°C, in an aerobic atmosphere. Stock clinical cultures were maintained in blood glycerol (16% [vol/vol]) broth on Preserver Beads (Technical Service Consultants, Heywood, Lancashire, United Kingdom) at
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C.
TABLE 1.
Strains of S. aureus studied and their
phenotypic features
Bacteriophage typing. This was done by the method described by Blair and Williams (5) at the RTD and a 100× RTD with the current set of international phages (3) and supplementary phages (32).
Enterotoxin production. Isolates were examined for the production of enterotoxins A, B, and C and toxic shock syndrome toxin 1 (TSST-1) by reverse passive latex agglutination according to the manufacturer's instructions (Oxoid Unipath).
Protein A production. A rapid, semiquantitative dot blot analysis was employed (33).
Urease production. Conventional urea slopes were inoculated with 100 to 200 µl of an overnight broth culture with a Pasteur pipette to ensure that the slope was inoculated evenly. Slopes were incubated at 37°C for up to 7 days (11).
DNA preparation. Two methods were used to prepare DNA from strains of S. aureus.
(i) Lysostaphin-sodium chloride-cetyltrimethylammonium bromide. Chromosomal DNA was isolated as described by Jones (21), with modifications. The bacteria were harvested from one-half the area of a blood agar plate, suspended in 1 ml of TE-glucose (25 mM Tris-HCl [pH 8.0], 10 mM EDTA [pH 8.0], 1.0% [wt/vol] D-glucose), and centrifuged at 7,500 × g for 5 min. The cells were resuspended in 100 µl of lysostaphin (1 mg/ml in TE-glucose; Sigma)-50 µl of lysozyme (50 mg/ml in TE-glucose; Sigma) and incubated at 37°C for 1 h. Eighty microliters of NaCl-cetyltrimethylammonium bromide solution (0.7 M NaCl, 10% [wt/vol] cetyltrimethylammonium bromide; Sigma) was added with mixing and incubated at 65°C for 10 min. Sodium chloride (100 µl of a 5 M stock solution), sodium dodecyl sulfate (30 µl of 10% [wt/vol] sodium dodecyl sulfate; Sigma), and proteinase K (4 mg of proteinase K; Sigma) were added with mixing and incubated at 55°C for 30 min. The lysate was extracted with equal volumes of phenol-chloroform, and the DNA was precipitated from the aqueous phase with 1 volume of isopropanol and resuspended in 100 µl of sterile distilled PCR-quality water (Sigma). The DNA concentration was determined by UV spectrophotometry at A260, and the extract was stored at 4°C. Extraction time was 1 to 2 days. Approximately 50 to 100 ng of DNA was taken for PCR amplification.
(ii) Chelex extraction. A half-loopful (approximately 25 µl) of bacterial growth was removed from a blood agar plate, suspended in 1 ml of TE-glucose, and centrifuged at 7,500 × g for 5 min. The cells were resuspended in 100 µl of lysostaphin solution plus 50 µl of lysozyme and incubated at 37°C for 1 h. One hundred microliters of a 5 M NaCl solution and 30 µl of proteinase K were added, and the lysate was incubated at 55°C for 30 min. Five microliters of the lysate was diluted in 45 µl of PCR-quality water. Ten microliters of Chelex 100 resin (sodium form; 100/200 mesh size; final concentration, 5% [wt/vol]; pH 7.0; Sigma)-Nonidet P-40 (Sigma; final concentration, 0.4% [vol/vol]) solution was added and incubated at 55°C for 30 min. The lysate was then overlayered with 2 drops of mineral oil (Sigma) and heated at 99°C for 20 min to denature the proteinase K. One microliter of lysate was taken for PCR amplification.
PCR amplification of the coagulase (coa) gene.
An oligonucleotide primer pair was designed by using the program Primer
(C. W. Dieffenbach, Department of Surgery and Pathology, Uniformed
Services University of the Health Sciences, Bethesda, Md.). To
encompass the entire 3' repeat elements and avoid the variable regions
within the coagulase gene primer sequences, 5'ATA GAG ATG CTG GTA CAG
G3' (1513 to 1531; nucleotide numbering according to the work of Kaida
et al. [23]; MRSA 213, accession no. X16457) and 5'GCT
TCC GAT TGT TCG ATG C3' (2188 to 2168) were chosen. Each amplification
in sterile thin-walled glass capillaries (Idaho Technologies, Idaho
Falls, Idaho) comprised DNA template, 75 pmol of each primer, 50 µM
(each) deoxynucleoside triphosphates (dATP, dCTP, dGTP, and dTTP), 1×
buffer (Gibco BRL), 3.0 mM MgCl2, 1× bovine serum albumin
(250 µg/ml; BioGene Limited, Kimbolton, Bedfordshire, United
Kingdom), and 12.5 U of Taq DNA polymerase (Gibco BRL). Filter-sterilized (0.22-µm pore size) PCR-quality water (Sigma) was
added to a final volume of 50 µl. Thermal cycling took place on a
hot-air Rapidcycler (Idaho Technologies) following an initial denaturation at 94°C for 45 s. The cycling proceeded for 30 cycles of 94°C for 20 s, 57°C for 15 s, and 70°C for
15 s with a final step at 72°C for 2 min. The size of the PCR
product (5-µl aliquot) was determined by comparison to the
X174
DNA/HaeIII markers (Bio-Rad Laboratories) by electrophoresis
on 1.0% (wt/vol) agarose gels.
DNA restriction endonuclease analysis of the PCR-amplified coagulase gene. Approximately 500 ng (7 to 10 µl) of PCR product was digested with 2 U of restriction endonuclease (AluI, CfoI, HinfI, and SacI; Boehringer Mannheim) at 37°C for 1 h 30 min. Twenty microliters of digested PCR product was analyzed by electrophoresis on 2.75% (wt/vol) agarose gels (FMC BioProducts).
DNA sequencing of the PCR-amplified coagulase gene. The 875- to 550-bp PCR-amplified fragments were purified according to the method of Zhen and Swank (42). PCR products were directly sequenced on both overlapping strands with DyeDeoxy Terminator kits (Applied Biosystems-Perkin-Elmer) according to the manufacturer's protocol with a 377 DNA sequencer. The primers used were those for PCR amplification.
Data analysis. Sequences were aligned against S. aureus 213 (accession no. X16457 [23]) and 8325-2 (accession no. Z33404 [30]) by using the program Multalin (10) (Cherwell Scientific Publishing Limited, Oxford, United Kingdom). Those base positions that could not be aligned unambiguously were removed. A total of 530 nucleotide bases for 28 strains comprised the final alignment; this is available from us on request. Evolutionary analyses were carried out with PHYLIP (J. Felsenstein, University of Washington, Seattle). The reliability of tree nodes was assessed by analyzing 1,000 data sets. Pairwise distances between sequences were inferred under the Jukes and Cantor (22) one-parameter model. Trees were constructed by using neighbor joining (NEIGHBOR [35]) and the algorithm of Fitch and Margoliash (FITCH [14]). A majority rule consensus tree was computed with the CONSENSE program. The bootstrap percentages quoted in the legend to Fig. 3 are the percentages of times that a taxon to the right of that node occurred, and they provide some indication of the stability of the branching order and the phylogenetic groupings.
| |
RESULTS |
|---|
|
|
|---|
Size variation in the 3' region of the coagulase gene. With the exception of the coagulase-negative strains, S. epidermidis NCTC 11047, S. haemolyticus NCTC 11042, and S. saprophyticus NCTC 7292, all strains examined produced a PCR amplicon. The four PCR products obtained were either 875 (±10 bp, n = 2), 660 (±20 bp, n = 10), 603 (±20 bp, n = 10), or 547 (±15 bp, n = 10) bp. All EMRSA-16 isolates gave a 547-bp product (Fig. 1A).
|
PCR RFLP patterns of the coagulase gene. PCR products were digested with AluI or CfoI, and the resulting fragments were separated (Fig. 1 and 2). No changes were observed in the sizes of the coagulase gene PCR products after repeated strain subcultivation (seven times) and DNA extraction. The mean values (standard errors of the means) from within-gel errors (n = 3) for duplicated strains were ± 10 bp for those fragments formed on AluI or CfoI digestion (Fig. 2).
|
Comparison of coagulase gene sequences. The 3' variable regions of the coagulase gene were sequenced for 26 isolates representing the 16 United Kingdom EMRSA strains and each of the 10 PCR RFLP patterns. Sequences were aligned, and pairwise distance measurements, based on 530 nucleotides for each strain, were used in the construction of a consensus phylogenetic tree (Fig. 3).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The object of this study was to determine whether PCR RFLP patterns of the coagulase gene could be used to differentiate the major epidemic United Kingdom strains of MRSA. The coagulase genes from 95 isolates, representing predominant United Kingdom EMRSA strains, the Jevons MRSA strain, and propagating strains (PS), were amplified by PCR, and the products were digested with both AluI and CfoI. In this study, the parallel use of two DNA restriction endonucleases to digest the coagulase gene was beneficial in confirming the 10 distinct RFLP patterns among S. aureus strains. In addition, PCR CfoI RFLP pattern analysis allowed the differentiation of five EMRSA-2 isolates (Fig. 2B, RFLP pattern 8); this was not possible with AluI.
Other authors have used PCR RFLP pattern analysis to study S. aureus, but only Tenover et al. (39) phage typed any of the strains. Furthermore, reference strains were not used, and differing PCR primers were employed (15, 25, 26, 29, 38, 39). It is therefore not possible to compare the results of this study with those of previous coagulase PCR RFLP pattern analyses.
The RFLP patterns 1, 2, and 3 were simple (three to four bands) and unique and allowed the typing of the important United Kingdom epidemic strains, EMRSA-3, EMRSA-15, and EMRSA-16 (Fig. 2). These EMRSA strains also clustered within the phylogenetically distinct groups A, B, and C, respectively (Table 2) (Fig. 3). In the light of coagulase PCR RFLP and sequence comparisons, most isolates with RFLP patterns 4 and 5 gave distinct groups D and G, respectively (Table 2) (Fig. 2 and 3). Isolates of EMRSA-2 were exceptional, in that they formed a single phylogenetic group (F) and yet gave two RFLP patterns, 5 and 8 (Table 2).
Isolates of MRSA from France (QC01 and QC07) and Spain (211 and 212) have given similar patterns on ribotyping, PFGE (2, 34), and coagulase typing (this study) and are thought to be representative of an epidemic clone circulating within Europe. In contrast, the German isolate 94/14013 was distinct and clearly separable from the other European isolates studied (2, 41) (Fig. 2 and 3).
The propagating strains, PS 42E and PS 71, represent some of the diverse types of isolates from human clinical material. They can be differentiated by ribotype (34) and by their unique coagulase RFLP patterns, 9 and 10, respectively (Fig. 2).
Isolate Airedale 16 has phage type EMRSA-15, and yet unlike other EMRSA-15 strains, it does not produce enterotoxin C, has a unique PCR RFLP pattern, and is atypical on PFGE (31). It is a sporadic outbreak strain which may have originated from horizontal genetic transfer of resistance genes from MRSA to methicillin-sensitive S. aureus (cf. reference 36). It is evident from the populations studied so far that antibiotic-sensitive strains exhibited greater genetic diversity than did resistant strains (reference 7 and this study).
This study demonstrates the value of PCR RFLP (AluI and CfoI) pattern analysis of the coagulase gene for the rapid initial genotyping of S. aureus, particularly of the major United Kingdom epidemic strains, EMRSA-3, EMRSA-15, and EMRSA-16. The RFLP patterns observed in this study were substantiated by the analysis of sequence data in that the patterns gave rise to parallel phylogenetic groups.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Philip P. Mortimer, Jonathan P. Clewley, and John Stanley for critical reading of the manuscript and to Jon White for artwork.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Biology Unit, Virus Reference Division, Central Public Health Laboratory, Colindale, London NW9 5HT, United Kingdom. Phone: (44) 181 200 4400. Fax: (44) 181 200 1569. E-mail: jhookey{at}hgmp.mrc.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anonymous. 1996. Epidemic methicillin resistant Staphylococcus aureus. Commun. Dis. Rep. 6:1. |
| 2. | Aparicio, P., J. Richardson, S. Martin, A. Vindel, R. R. Marples, and B. D. Cookson. 1992. An epidemic methicillin-resistant strain of Staphylococcus aureus in Spain. Epidemiol. Infect. 108:287-298[Medline]. |
| 3. | Asheshov, E. H., and R. Skalova. 1975. International Committee on Systematic Bacteriology. Subcommittee on the Phage-Typing of Staphylococci. Minutes of the meeting, 26 September 1974. Int. J. Syst. Bacteriol. 25:233-234. |
| 4. | Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555[Abstract]. |
| 5. | Blair, J. E., and R. E. O. Williams. 1961. Phage typing of staphylococci. Bull. W. H. O. 24:771-784. |
| 6. | Byrne, M. E., T. G. Littlejohn, and R. A. Skurray. 1990. Transposons and insertion sequences in the evolution of multiresistant Staphylococcus aureus, p. 165-174. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers, New York, N.Y. |
| 7. |
Carles-Nurit, M. J.,
B. Christophle,
S. Broche,
A. Gouby,
N. Bouziges, and M. Ramuz.
1992.
DNA polymorphisms in methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.
J. Clin. Microbiol.
30:2092-2096 |
| 8. | Cookson, B., H. Talsania, J. Naidoo, and I. Phillips. 1986. Strategies for typing and properties of epidemic methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. 5:702-709[Medline]. |
| 9. | Cookson, B. D., P. Aparicio, A. Deplano, M. Struelens, R. Goering, and R. Marples. 1996. Inter-centre comparison of pulsed-field gel electrophoresis for the typing of methicillin-resistant Staphylococcus aureus. J. Med. Microbiol. 44:179-184[Abstract]. |
| 10. |
Corpet, F.
1988.
Multiple sequence alignment with hierarchical clustering.
Nucleic Acids Res.
16:10881-10890 |
| 11. | Cowan, S. T. 1974. Characterization tests, p. 166-180. In S. T. Cowan (ed.), Cowan and Steel's manual for the identification of medical bacteria, 2nd ed. Cambridge University Press, Cambridge, United Kingdom. |
| 12. | Cox, R. A., C. Conquest, C. Mallaghan, and R. R. Marples. 1995. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J. Hosp. Infect. 29:87-106[Medline]. |
| 13. | Cuny, C., H. Claus, and W. Witte. 1996. Discrimination of S. aureus by PCR for r-RNA gene spacer size polymorphism and comparison to SmaI macrorestriction patterns. Zentralbl. Bakteriol. 283:466-476[Medline]. |
| 14. |
Fitch, W. M., and E. Margoliash.
1967.
Construction of phylogenetic trees. A method based on mutation distances as estimated from cytochrome c sequences is of general applicability.
Science
155:279-284 |
| 15. |
Goh, S.-H.,
E. E. Byrne,
J. L. Zhang, and A. W. Chow.
1992.
Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms.
J. Clin. Microbiol.
30:1642-1645 |
| 16. | Grubb, W. B. 1990. Molecular epidemiology of methicillin-resistant S. aureus, p. 595-606. In R. Novick (ed.), Molecular biology of the staphylococci. VHC Publishers, New York, N.Y. |
| 17. | Gurtler, V., and H. D. Barrie. 1995. Typing of Staphylococcus aureus strains by PCR-amplification of variable-length 16S-23S rDNA spacer regions: characterization of spacer sequences. Microbiology 141:1255-1265[Abstract]. |
| 18. |
Hartstein, A. I.,
V. H. Morthland,
S. Eng,
G. L. Archer,
F. D. Schoenknecht, and A. L. Rasad.
1989.
Restriction enzyme analysis of plasmid DNA and bacteriophage typing of paired Staphylococcus aureus blood culture isolates.
J. Clin. Microbiol.
27:1874-1879 |
| 19. | Jarlov, J. O., V. T. Rosdahl, M. Yeo, and R. R. Marples. 1993. Lectin-typing of methicillin-resistant Staphylococcus aureus from Singapore, England & Wales, and Denmark. J. Med. Microbiol. 39:305-309[Abstract]. |
| 20. | Jevons, M. P. 1961. "Celbenin"-resistant staphylococci. Br. Med. J. 1:124-125. |
| 21. | Jones, A. S. 1953. The isolation of bacterial nucleic acids using cetyltrimethylammonium bromide (CETAVLON). Biochim. Biophys. Acta 40:273-286. |
| 22. | Jukes, T. H., and C. R. Cantor. 1969. Evolution of protein molecules, p. 21-132. In H. N. Munro (ed.), Mammalian protein metabolism. Academic Press, New York, N.Y. |
| 23. |
Kaida, S.,
T. Miyata,
Y. Yoshizawa,
H. Igarashi, and S. Iwanage.
1989.
Nucleotide and deduced amino acid sequence of staphylocoagulase gene from Staphylococcus aureus strain 213.
Nucleic Acids Res.
17:8871 |
| 24. | Kloos, W. E., and K. H. Schleifer. 1986. Family I. Micrococcaceae. Genus IV. Staphylococcus, Rosenbach 1884, 18AL, p. 1013-1035. In P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. Williams & Wilkins, Baltimore, Md. |
| 25. | Kobayashi, N., K. Tanguchi, K. Kojima, S. Urasawa, N. Uehara, Y. Omizu, A. Yagihashi, and I. Kurokawa. 1995. Analysis of methicillin-resistant and methicillin-susceptible Staphylococcus aureus by a molecular typing method based on coagulase gene polymorphism. Epidemiol. Infect. 115:419-426[Medline]. |
| 26. |
Lawrence, C.,
M. Cosseron,
O. Mimoz,
C. Brun-Buisson,
Y. Costa,
K. Sammii,
J. Duval, and R. Leclercq.
1996.
Use of the coagulase gene typing method for the detection of carriers of methicillin-resistant Staphylococcus aureus.
J. Antimicrob. Chemother.
37:687-696 |
| 27. | Marples, R. R., and E. M. Cooke. 1988. Current problems with methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 11:381-392[Medline]. |
| 28. |
Mulligan, M. E.,
R. Y. Kwok,
D. M. Citron,
J. J. John, and P. B. Smith.
1988.
Immunoblots, antimicrobial resistance, and bacteriophage typing of oxicillin-resistant Staphylococcus aureus.
J. Clin. Microbiol.
26:2395-2401 |
| 29. | Nada, T., S. Ichiyama, Y. Osada, M. Ohta, K. Shimokata, N. Kato, and N. Nakashima. 1996. Comparison of DNA fingerprinting by PFGE and PCR-RFLP of the coagulase gene to distinguish MRSA isolates. J. Hosp. Infect. 32:305-317[Medline]. |
| 30. | Phonimdaeng, P., M. O'Reilly, P. Nowlan, A. Bramley, and N. Foster. 1990. The coagulase of Staphylococcus aureus 8325-4: sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol. Microbiol. 4:393-404[Medline]. |
| 31. | Richardson, J. F., and S. Reith. 1993. Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J. Hosp. Infect. 25:45-52[Medline]. |
| 32. | Richardson, J. F., N. Chittasobhon, and R. R. Marples. 1988. A supplementary phage set for the investigation of methicillin-resistant strains of Staphylococcus aureus. J. Med. Microbiol. 25:67-74[Abstract]. |
| 33. | Richardson, J. F., A. H. M. Quoraishi, B. J. Francis, and R. R. Marples. 1990. Beta-lactamase negative, methicillin-resistant Staphylococcus aureus in a newborn nursery: report of an outbreak and laboratory investigations. J. Hosp. Infect. 16:109-121[Medline]. |
| 34. | Richardson, J. F., P. Aparicio, R. R. Marples, and B. D. Cookson. 1994. Ribotyping of Staphylococcus aureus: an assessment using well defined strains. Epidemiol. Infect. 112:93-101[Medline]. |
| 35. | Saitou, N., and M. Nei. 1987. The neighbour joining method: a new method for constructing phylogenetic trees. Mol. Biol. Evol. 4:406-425[Abstract]. |
| 36. | Schneider, C., M. Weindel, and V. Brade. 1996. Frequency, clonal heterogeneity and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) isolated in 1992-1994. Zentralbl. Bakteriol. 283:529-542[Medline]. |
| 37. | Schumacher-Perdreau, F., B. Jansen, H. Seifert, G. Peters, and G. Pulverer. 1994. Outbreak of methicillin-resistant Staphylococcus aureus in a teaching hospital: epidemiological and microbiological surveillance. Zentralbl. Bakteriol. 280:550-559[Medline]. |
| 38. |
Schwarzkopf, A., and H. Karch.
1994.
Genetic variation in Staphylococcus aureus coagulase genes: potential and limits for use as an epidemiological marker.
J. Clin. Microbiol.
32:2407-2412 |
| 39. |
Tenover, F. C.,
R. Arbeit,
G. Archer,
J. Biddle,
S. Byrne,
R. Goering,
G. Hancock,
G. A. Hébert,
B. Hill,
R. Hollis,
W. R. Jarvis,
B. Kreiswirth,
W. Eisner,
J. Maslow,
L. K. McDougal,
J. M. Miller,
M. Mulligan, and M. A. Pfaller.
1994.
Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus.
J. Clin. Microbiol.
32:407-415 |
| 40. | Thomson-Carter, F. M., P. E. Carter, T. M. Purcell, and T. H. Pennington. 1994. Application of genotypic techniques in analyses of staphylococcal infections, p. 103-107. In T. Wadstrom, and I. A. Holder (ed.), Molecular pathogenesis of surgical infections. Gustav Fischer Verlag, Stuttgart, Germany. |
| 41. | Witte, W., C. Cuny, C. Braulke, and D. Hueck. 1994. Clonal dissemination of two MRSA strains in Germany. Epidemiol. Infect. 113:67-73[Medline]. |
| 42. | Zhen, L., and R. T. Swank. 1993. A simple and high yield method for recovering DNA from agarose gels. BioTechniques 14:894-898[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|